| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.24 |
9e-06 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.22 |
9e-05 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.23 |
0.0001 |
| mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
| mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.19 |
0.0002 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
| mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.2 |
0.0006 |
| mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0007 |